A. Guerci-Bresler

501 total citations
8 papers, 171 citations indexed

About

A. Guerci-Bresler is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, A. Guerci-Bresler has authored 8 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in A. Guerci-Bresler's work include Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). A. Guerci-Bresler is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). A. Guerci-Bresler collaborates with scholars based in United States, Italy and France. A. Guerci-Bresler's co-authors include Bernard Roubert, K Taylor, Mathias Schmid, Michael Stadler, Dany Habr, Matteo Giovanni Della Porta, Carlo Finelli, Christian Rose, Pierre Fenaux and Nelma Clementino and has published in prestigious journals such as Journal of Clinical Oncology, Leukemia and Quality of Life Research.

In The Last Decade

A. Guerci-Bresler

8 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Guerci-Bresler United States	4	161	145	24	14	12	8	171
Jason Esposito United States	8	303 1.9×	278 1.9×	6 0.3×	24 1.7×	13 1.1×	15	332
Precious Pearl Landburg Netherlands	5	75 0.5×	108 0.7×	7 0.3×	35 2.5×	7 0.6×	8	149
G. Barosi Italy	6	41 0.3×	50 0.3×	16 0.7×	15 1.1×	23 1.9×	11	101
Dimana Miteva United States	7	124 0.8×	134 0.9×	4 0.2×	24 1.7×	7 0.6×	27	169
Nathalie Cheikh France	4	63 0.4×	44 0.3×	14 0.6×	11 0.8×	2 0.2×	8	82
Dominique Steschenko France	5	73 0.5×	80 0.6×	17 0.7×	56 4.0×	5 0.4×	10	161
Agostina Siniscalchi Italy	7	87 0.5×	23 0.2×	11 0.5×	54 3.9×	44 3.7×	16	107
Aimee Jackson United Kingdom	5	41 0.3×	31 0.2×	8 0.3×	22 1.6×	17 1.4×	14	85
Alex Allepuz Switzerland	6	100 0.6×	72 0.5×	36 1.5×	12 0.9×	18 1.5×	15	134
J Arlet France	4	61 0.4×	82 0.6×	6 0.3×	24 1.7×	8 0.7×	14	123

Countries citing papers authored by A. Guerci-Bresler

Since Specialization

Citations

This map shows the geographic impact of A. Guerci-Bresler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Guerci-Bresler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Guerci-Bresler more than expected).

Fields of papers citing papers by A. Guerci-Bresler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Guerci-Bresler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Guerci-Bresler. The network helps show where A. Guerci-Bresler may publish in the future.

Co-authorship network of co-authors of A. Guerci-Bresler

This figure shows the co-authorship network connecting the top 25 collaborators of A. Guerci-Bresler. A scholar is included among the top collaborators of A. Guerci-Bresler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Guerci-Bresler. A. Guerci-Bresler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Foulon, Stéphanie, et al.. (2021). Health state utility and quality of life measures in patients with chronic myeloid leukemia in France. Quality of Life Research. 30(7). 2021–2032. 5 indexed citations

Hughes, Timothy P., Brian Leber, Francisco Cervantes, et al.. (2017). Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results. Leukemia. 31(11). 2529–2531. 31 indexed citations

Finelli, Carlo, Matteo Giovanni Della Porta, Pierre Fenaux, et al.. (2012). Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes. Haematologica. 97(9). 1364–1371. 124 indexed citations

Gyan, Emmanuel, Valérie Andrieu‐Ponel, A. Caillé, et al.. (2011). 59 Myelodysplastic syndromes with isolated neutropenia or thrombocytopenia: Are they refractory cytopenias with unilineage dysplasia? A GFM registry study. Leukemia Research. 35. S22–S22. 1 indexed citations

Gattermann, Norbert, Carlo Finelli, Matteo Giovanni Della Porta, et al.. (2011). 340 Improvement in haematologic parameters in patients with MDS treated with the iron chelator deferasirox (Exjade®): An EPIC study post-hoc analysis. Leukemia Research. 35. S136–S137. 1 indexed citations

Gattermann, Norbert, Mathias Schmid, A. Guerci-Bresler, et al.. (2009). P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS). Leukemia Research. 33. S140–S141. 4 indexed citations

Sekeres, Mikkael A., H. Kantarjian, Pierre Fenaux, et al.. (2009). Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with myelodysplastic syndrome (MDS). Journal of Clinical Oncology. 27(15_suppl). 7009–7009. 3 indexed citations

Schmid, Mathias, A. Guerci-Bresler, Matteo Giovanni Della Porta, et al.. (2009). P141 Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS). Leukemia Research. 33. S141–S142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact